Back

Why do we need to combine antiplatelets and anticoagulants?

4 March 2018 (11:00 - 11:18)
Organised by:
Congress Presentation Part of: Anti-thrombotics in patients at simultaneous risk of stroke and stent thrombosis Cardiovascular Pharmacotherapy ACVC Premium Access Acute Cardiovascular Care 2018

About the speaker

Photo
Professor Raffaele De Caterina

University of Pisa, Pisa (Italy)

4 More presentations in this session

Presentation thumbnail
Rational to remove aspirin from the cocktail. The story after WOEST...(VIA ZOOM)
Professor J. ten Berg (Nieuwegein, NL)
Video
Presentation thumbnail
What have we learned in the era of NOACs.
Professor F. Verheugt (Amsterdam, NL)
Slides Video
Presentation thumbnail
Type of stent, type of antiplatelet, type of anticoagulant. The triad of success.
Doctor G. Casella (Bologna, IT)
Slides Video
Presentation thumbnail
Ultra-low-dose twice-daily aspirin improves haemostasis and maintains platelet inhibition in acute coronary syndrome patients receiving ticagrelor
Doctor W. Parker (Sheffield, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Anti-thrombotics in patients at simultaneous risk of stroke and stent thrombosis

The Event

Event poster

Acute Cardiovascular Care 2018

4 March 2018 11:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources